OBJECTIVES: To determine the diagnostic value of a blood interferon-gamma release assay in suspected active tuberculosis (TB). METHODS: 136 subjects with suspected pulmonary TB (pTB) at a single London centre with intermediate TB incidence, were clinically graded into low (<25%), medium, or high (>75%) likelihood of active pTB and then tested by T-SPOT®.TB assay. The diagnosis was confirmed by culture (n = 33), treatment response (n = 13) or a firm alternative diagnosis (n = 90). RESULTS: Overall, the T-SPOT.TB sensitivity was 74% (95% confidence intervals 60-84%), positive predictive value (PPV) 56% (43-68%), negative predictive value (NPV) 83% (71-90%), positive likelihood ratio (PLR) 1.75 and negative likelihood ratio (NLR) 0.45. Results for high pTB likelihood subjects: PPV 100%, NPV 25% (7-60%), PLR >69, NLR 0.31. Results for intermediate pTB likelihood subjects: PPV 67% (41-85%), NPV 88% (65-96%), PLR 2.39, NLR 0.26. Results for low pTB likelihood subjects: PPV 15% (6-34%), NPV 92% (79-97%), PLR 1.23, NLR 0.80. False negatives occurred in 24% of cases of active tuberculosis (4 smear and culture-positive, 3 smear negative and culture-positive, and 4 culture negative). CONCLUSIONS: The predictive values and likelihood ratios show the T-SPOT.TB test does not assist in confidently confirming or excluding active TB, regardless of the pre-test probability of disease.
OBJECTIVES: To determine the diagnostic value of a blood interferon-gamma release assay in suspected active tuberculosis (TB). METHODS: 136 subjects with suspected pulmonary TB (pTB) at a single London centre with intermediate TB incidence, were clinically graded into low (<25%), medium, or high (>75%) likelihood of active pTB and then tested by T-SPOT®.TB assay. The diagnosis was confirmed by culture (n = 33), treatment response (n = 13) or a firm alternative diagnosis (n = 90). RESULTS: Overall, the T-SPOT.TB sensitivity was 74% (95% confidence intervals 60-84%), positive predictive value (PPV) 56% (43-68%), negative predictive value (NPV) 83% (71-90%), positive likelihood ratio (PLR) 1.75 and negative likelihood ratio (NLR) 0.45. Results for high pTB likelihood subjects: PPV 100%, NPV 25% (7-60%), PLR >69, NLR 0.31. Results for intermediate pTB likelihood subjects: PPV 67% (41-85%), NPV 88% (65-96%), PLR 2.39, NLR 0.26. Results for low pTB likelihood subjects: PPV 15% (6-34%), NPV 92% (79-97%), PLR 1.23, NLR 0.80. False negatives occurred in 24% of cases of active tuberculosis (4 smear and culture-positive, 3 smear negative and culture-positive, and 4 culture negative). CONCLUSIONS: The predictive values and likelihood ratios show the T-SPOT.TB test does not assist in confidently confirming or excluding active TB, regardless of the pre-test probability of disease.
Authors: M Sester; G Sotgiu; C Lange; C Giehl; E Girardi; G B Migliori; A Bossink; K Dheda; R Diel; J Dominguez; M Lipman; J Nemeth; P Ravn; S Winkler; E Huitric; A Sandgren; D Manissero Journal: Eur Respir J Date: 2010-09-16 Impact factor: 16.671
Authors: Alasdair R J Bamford; Angela M Crook; Julia E Clark; Zohreh Nademi; Garth Dixon; James Y Paton; Anna Riddell; Francis Drobniewski; Andrew Riordan; Suzanne T Anderson; Amanda Williams; Sam Walters; Beate Kampmann Journal: Arch Dis Child Date: 2009-10-08 Impact factor: 3.791
Authors: A Catanzaro; S Perry; J E Clarridge; S Dunbar; S Goodnight-White; P A LoBue; C Peter; G E Pfyffer; M F Sierra; R Weber; G Woods; G Mathews; V Jonas; K Smith; P Della-Latta Journal: JAMA Date: 2000-02-02 Impact factor: 56.272
Authors: Gerald H Mazurek; Stephen E Weis; Patrick K Moonan; Charles L Daley; John Bernardo; Alfred A Lardizabal; Randall R Reves; Sean R Toney; Laura J Daniels; Philip A LoBue Journal: Clin Infect Dis Date: 2007-08-24 Impact factor: 9.079
Authors: Davinder P S Dosanjh; Timothy S C Hinks; John A Innes; Jonathan J Deeks; Geoffrey Pasvol; Sarah Hackforth; Hansa Varia; Kerry A Millington; Rubamalar Gunatheesan; Valerie Guyot-Revol; Ajit Lalvani Journal: Ann Intern Med Date: 2008-03-04 Impact factor: 25.391